IMMX

Immix Biopharma, Inc. Common Stock

$9.22 +2.44%

Recent alerts on IMMX

All signals →

SEC filing IMMX Prices $150M Underwritten Offering of 16.8M Shares at $8.94 per Share

News Immix Biopharma prices $150M stock offering at $8.94/share

News Immix rises after mid-stage trial data for AL amyloidosis therapy

SEC filing IMMX Reports 95% Complete Response Rate in NEXICART-2 Trial for Relapsed/Refractory AL Amyloidosis, Plans Phase 3 Trial Initiation

News Immix rises as Morgan Stanley starts with bullish view on CAR-T therapy

Get push alerts for IMMX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS